Current Research
Post-transcriptional Regulation by
small non-coding RNAs and Hfq in Eubacteria and by Initiation Factors in
Archaea
Regulation of translation
initiation in response to environmental stimuli has become a major theme in
bacterial gene expression and pathogenicity.
Our main interests focus on translational control mechanisms exerted by
small regulatory RNAs and by the RNA chaperone Hfq in Eubacteria as well as on
the regulatory function of different initiation factors on translation in the archaeon Sulfolobus solfataricus.
Hfq, sRNAs
and bacterial virulence.
Bacteria are constantly challenged by
changing environmental conditions. They
employ a number of translational control mechanisms including trans-acting proteins, small non-coding
RNAs (sRNAs) as well as features inherent to mRNA structure, which permit a
fast adaptation to new environments or to different kinds of stress. E. coli
host factor I (Hfq) has a hexameric ring-shaped structure and belongs to the
large family of Sm and Sm-like proteins with RNA binding activity. The work on Hfq was initiated by our
observation that translation initiation of the E. coli ompA gene is mediated by Hfq. This work directly demonstrated
that a 30S ribosome bound to the ompA 5'-UTR protected the
transcript from RNase E cleavage, and thereby contributed to a better
understanding of the interrelation between translation (initiation) and mRNA
turnover. Subsequent work revealed that Hfq induces
structural changes in RNA and that it functions as genuine RNA chaperone. In Gram-negative
Bacteria, Hfq acts as a global regulator involved in post-transcriptional
regulation and virulence. Hfq
binds to a number of sRNAs, contributes to their stability, and is often required for translational silencing
and activation mediated by these riboregulators. At present, it is poorly understood how the
protein interacts with sRNAs and their mRNA substrates. Therefore, a collaborative effort between my
group and the Djinovic-Carugo group (MFPL, Vienna Biocenter) concerns the
elucidation of the complete 3D-structure of Hfq and that of Hfq-RNA complexes. Hfq has been shown to localize to the 30S
ribosomal subunit. Ongoing research
projects are aimed at defining (i) the molecular environment of Hfq on the 30S
subunit, (ii) Hfq interacting proteins involved in post-transcriptional
processes, (iii) the molecular events underlying sRNA-based mRNA silencing, and
(iv) the molecular events leading to decay or stabilization of sRNA/mRNAs
complexes. In the context of (iii), we
were recently able to demonstrate that a sRNA does not necessarily regulate
translation of a target mRNA in a direct manner, i.e. by binding to or in the
vicinity of its ribosome binding site but can do so by regulation of an upstream
open reading frame to which the downstream gene is translationally
coupled. In addition, this work provided
evidence for an iron-dependent decoding mechanism of mRNAd encoding
iron-containing proteins.
Pseudomonas
aeruginosa (PAO1) is a major cause of hospital acquired infections, exerts the highest
case fatality rate among Gram-negative pathogens, and contributes to mortality in
cystic fibrosis patients. As we have
previously shown that a PAO1 hfq- mutant was significantly attenuated in
virulence, it can be anticipated that ncRNAs are involved in regulation of many
virulence genes. The complexity of
post-transcriptional regulation mediated by Hfq became apparent when we
compared the transcriptome profiles of PAO1 with the of an isogenic hfq- mutant. The complex regulatory circuit affected by
Hfq involved stabilization of a regulatory RNA, which indirectly affects a
regulatory cascade, mediating virulence gene expression. The ongoing and future
P. aeruginosa project, which is currently the major topic in my
laboratory, is concentrating on the following topics: (i) detection of sRNAs
under various stress conditions, including identification of Hfq-binding sRNAs
from clinical P. aeruginosa strains present in the sputum of cystic
fibrosis patients, and (ii) validation of their potential target genes using biochemical
and genetic methods. It is anticipated
that these approaches will reveal sRNAs involved in virulence gene expression,
i.e. in post-transcriptional regulation of the PAO1 pathogenome. To this end we have obtained evidence that some
of the identified and characterized sRNAs impact on multi-drug resistance in
PAO1 and on synthesis of the virulence factor pyocyanin.
Post-transcriptional
regulation in the archaeon Sulfolobus
solfataricus.
In contrast to Bacteria and
Eukaryotes, the process of protein biosynthesis (translation), particularly
that of translation initiation, is poorly understood in Archaea, representing
the third domain of life. We have
chosen the thermophilic archaeon S. solfataricus
as a model system because its genome sequence is completed. This allowed cloning and purification of
different translation initiation factors, the functions of which we are
currently exploring. We were
able to demonstrate that the trimeric SSO translation initiation factor 2
(a/eIF2) is, like its eukaryotic counterpart eIF2, pivotal for delivery of
initiator tRNA to the ribosome. However,
in contrast to the eukaryal protein, the γ-subunit of a/eIF2 does
possesses an intrinsic capacity for tRNAi binding, which could suggest that the
γ-subunit functioned as a monomer earlier in evolution. Nevertheless, a stable interaction
with charged tRNAi required the presence of both, the α- and γ-subunits,
whereas in Eukaryotes the α- and β-subunit are required. These differences can be explained in light
of the crystal structures of the
a/eIF2-γ subunit and that of the trimeric factor, which have been elucidated in
collaboration with the Garber laboratory (
Phage-derived
Proteins as novel Antimicrobials
The appearance of multi-resistant
bacterial pathogens has become a serious threat. An alternative to antibiotics to treat
bacterial infections is the use of bacteriophage-derived proteins. A biotechnology driven project focuses on engineering
of genetically modified antimicrobial peptides specific for the human pathogen
Staphylococcus aureus with the aim to generate safe and highly specific therapeutic
agents.
Antimicrobial
activity of phage derived virion proteins.
For more than a
decade work in my laboratory has focused on molecular mechanism
underlying phage induced lysis of bacteria with particular emphasis on Lambda-induced lysis of E.coli. In 1999, this work revealed
the molecular mechanism by which the dual-start motif of the Lambda S-holin
schedules lysis timing of the host cell.
Although, the major emphasis of our research is on post-transcriptional
control mechanisms in Prokaryotes, I have continued with phage research on a
small scale. The expertise gained during
the “Lambda period" was employed for the construction of therapeutic
phage, which rescued mice from lethal P.
aeruginosa infections. As a
by-product we discovered that a combination treatment with certain phage and
antibiotics increases the sensitivity of P.
aeruginosa towards several antibiotics, providing a means to reduce the effective
dose of antibiotics that exert a high toxicity.
Moreover, together with the
Günzburg laboratory (
Phage encoded murein hydrolases are either part of the lysis cassette (endolysins) or found as structural components of the phage virion (exolysins). Our work on S. aureus phage P68 showed that it contains an exolysin, which displayed an antimicrobial activity towards clinical S. aureus isolates. In ongoing work, we have created and optimized the efficacy of chimeric enzymes, possessing the muralytic activity of the P68 endolysin and the cell wall targeting domain of the P68 exolysin. We could show that the recombinant enzymes have a high specificity for S. aureus. This applied project is anticipated to serve as a starting point for the development of specific and efficient antimicrobials against clinical S. aureus strains, which are resistant to commonly used antibiotics.